https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2014.00167/full
Frontiers | Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of...
The development of wild-type, unmodified Type 3 Dearing (T3D) strain reovirus as an anticancer agent has currently expanded to 32 clinical trials (both compl...